- United States
- /
- Personal Products
- /
- NYSE:EL
How Investors Are Reacting To Estée Lauder Companies (EL) Proposed Charter Amendments and Governance Changes
Reviewed by Sasha Jovanovic
- Estée Lauder Companies recently announced it will propose amendments to its Restated Certificate of Incorporation at its upcoming annual general meeting scheduled for November 13, 2025.
- This move has generated considerable interest as amendments of this nature can have a direct impact on shareholder rights and company governance.
- We'll examine how potential changes to Estée Lauder's corporate structure could influence its investment outlook and strategic direction.
We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
Estée Lauder Companies Investment Narrative Recap
To be a shareholder in Estée Lauder Companies right now, you need to believe in the company’s ability to return to profitable growth through global expansion, digital adoption, and ongoing product innovation. The recently proposed amendments to Estée Lauder’s Certificate of Incorporation are unlikely to materially impact the pressing short-term catalyst: a rebound in travel retail and normalization of sales in Asia. The immediate risks from continued soft consumer sentiment and cost pressures remain unchanged by this governance news.
Amidst these developments, Estée Lauder’s earnings announcement in August 2025 stands out: sales and earnings have declined year-over-year, yet the company reaffirmed its guidance for a return to positive sales growth and profitability in the next fiscal year. This cautious optimism hinges on effective execution in both established and emerging markets, reinforcing that investors will likely be watching near-term revenue recovery and margin improvements most closely.
But while underlying growth initiatives continue, what could really catch investors off guard is if prolonged weakness in the travel retail segment persists longer than expected, and...
Read the full narrative on Estée Lauder Companies (it's free!)
Estée Lauder Companies' outlook anticipates $16.0 billion in revenue and $1.4 billion in earnings by 2028. This is based on a 3.9% annual revenue growth rate and a $2.5 billion increase in earnings from the current $-1.1 billion.
Uncover how Estée Lauder Companies' forecasts yield a $91.43 fair value, a 4% upside to its current price.
Exploring Other Perspectives
Eleven Simply Wall St Community members estimate a wide US$60.66 to US$152 fair value range for Estée Lauder. As you weigh these diverse perspectives, keep in mind that current risks around global travel retail recovery may sharply influence outcomes for the business.
Explore 11 other fair value estimates on Estée Lauder Companies - why the stock might be worth as much as 73% more than the current price!
Build Your Own Estée Lauder Companies Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Estée Lauder Companies research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Estée Lauder Companies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Estée Lauder Companies' overall financial health at a glance.
Curious About Other Options?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.
- Outshine the giants: these 24 early-stage AI stocks could fund your retirement.
- The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Estée Lauder Companies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:EL
Estée Lauder Companies
Manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide.
Reasonable growth potential and slightly overvalued.
Similar Companies
Market Insights
Community Narratives

